[SciVision Biotech Inc.] 2026 Q1 EPS 0.29
NQ Score
0/100
N1 Content Completeness
85
AI Summary (NQ-processed)
SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.